The kinetics of carnitine palmitoyltransferase I (CPT I; EC 2.3.1.21) were examined in mitochondria from rat liver, heart and skeletal muscle as a function of pH over the range 6.8-7.6. In all three tissues raising the pH resulted in a fall in the Km for carnitine, no change in the Km for palmitoyl-CoA or octanoyl-CoA, and a marked decrease in the inhibitory potency of malonyl-CoA. Studies with skeletal-muscle mitochondria established that increasing pH was accompanied by an increase in the Kd of the malonyl-CoA binding site for this ligand, coupled with a decrease in the Kd for fatty acyl-CoA species to compete for malonyl-CoA binding. Three principal conclusions are drawn. (1) The pH-induced shift in malonyl-CoA sensitivity of CPT I is not a phenomenon restricted to liver mitochondria. (2) At any given pH within the range tested, the ability of malonyl-CoA (and closely related compounds) to inhibit enzyme activity is governed by the efficiency of their binding to the malonyl-CoA site. (3) The competitive interaction between fatty acyl-CoA substrates and malonylCoA as regards CPT I activity is exerted at the malonyl-CoA binding site. Finally, the possibility is strengthened that the malonyl-CoA binding site is distinct from the active site of CPT I.
The kinetics of carnitine palmitoyltransferase I (CPT I; EC 2.3.1.21) were examined in mitochondria from rat liver, heart and skeletal muscle as a function of pH over the range 6.8-7.6. In all three tissues raising the pH resulted in a fall in the Km for carnitine, no change in the Km for palmitoyl-CoA or octanoyl-CoA, and a marked decrease in the inhibitory potency of malonyl-CoA. Studies with skeletal-muscle mitochondria established that increasing pH was accompanied by an increase in the Kd of the malonyl-CoA binding site for this ligand, coupled with a decrease in the Kd for fatty acyl-CoA species to compete for malonyl-CoA binding. Three principal conclusions are drawn.
(1) The pH-induced shift in malonyl-CoA sensitivity of CPT I is not a phenomenon restricted to liver mitochondria. (2) At any given pH within the range tested, the ability of malonyl-CoA (and closely related compounds) to inhibit enzyme activity is governed by the efficiency of their binding to the malonyl-CoA site. (3) The competitive interaction between fatty acyl-CoA substrates and malonylCoA as regards CPT I activity is exerted at the malonyl-CoA binding site. Finally, the possibility is strengthened that the malonyl-CoA binding site is distinct from the active site of CPT I.
The kinetics of mitochondrial carnitine palmitoyltransferase I (CPT I, EC 2.3.1.21) vary greatly, depending on the tissue studied. For example, in the rat the enzyme from heart and skeletal muscle displays a Km for carnitine some 6-and 16-fold greater, respectively, than that from liver . Sensitivity of the enzyme to inhibition by malonyl-CoA spans an even wider range (about 100-fold), and appears to be positively correlated with the Km for carnitine (Saggerson & Carpenter, 1981a; McGarry et al., 1983; Mills et al., 1983) . Moreover, compounds structurally related to malonyl-CoA, such as succinyl-CoA and methylmalonyl-CoA, which are weak inhibitors of CPT I in liver, become increasingly more effective in heart and skeletal muscle .
To gain further insight into the mechanism of the malonyl-CoA-CPT I interaction, we have studied the rat muscle enzyme in more detail, because of its extreme sensitivity to the inhibitor.
Abbreviation used CPT I, carnitine palmitoyltransferase I (EC 2.3.1.21).
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It was established that mitochondria from this source possess a high-affinity binding site for [14C]malonyl-CoA, that this site also binds succinyl-CoA and methylmalonyl-CoA (though with successively less avidity than for malonyl-CoA), and that the activity of CPT I is governed by the degree of site occupancy, regardless of which inhibitor is employed . Substrates for CPT I, such as palmitoyl-CoA and octanoyl-CoA, were shown to displace malonylCoA from its binding site , consistent with previous reports that malonyl-CoA acts competitively with fatty acyl-CoA species towards the membrane-bound enzyme (McGarry et al., 1978a; Bremer, 1981; Saggerson & Carpenter, 1981b Binding assays were performed as described previously , except that the pH of the medium was varied from 6.8 to 7.6 and the labelled ligand used was [2-14C] 
Results

Effects ofpH on the kinetics of CPT I
The marked effect of pH on the inhibition of liver CPT I by malonyl-CoA, previously noted by Stephens et al. (1983) , was confirmed. Raising the pH of the assay medium from a starting value of 6.8 resulted in a progressively rightward shift of the activity-versus-[malonyl-CoA] response curve, such that at pH 7.6 the 150 (the concentration of malonyl-CoA required for 50% suppression of enzyme activity) had increased almost 8-fold (results not shown).
As noted in Fig. 1 , the same phenomenon was observed with mitochondria from heart and skeletal muscle, although, as expected on the basis of previous studies , at any given pH the inhibitory potency of malonyl-CoA increased in the sequence liver < heart < skeletal muscle. Table 1 documents the effect of pH on the apparent kinetic constants of the CPT I reaction in mitochondria from liver, heart and skeletal muscle. W-hen the concentration of palmitoyl-CoA was fixed at 5O0Mm, two points about the Km for carnitine are noteworthy. First, at any given pH the apparent Km was some 6-and 18-fold higher, respectively, in heart and skeletal muscle than in liver, in keeping with our previous report . Second, in all three tissues the value fell by a factor of 2 as the pH increased from 6.8 to 7.6. Calculated values for Vmax. the Km for palmitoyl-CoA did not change with pH, and in absolute terms its value, though highest in heart, was of similar magnitude (20-40,UM) in all three systems. Under these conditions Vmax. in liver was unaffected by pH, but in heart and skeletal muscle it increased 2-fold as the pH was raised from 6.8 to 7.6. Presumably this stemmed from the fact that, within the pH range tested, the. concentration of carnitine used was always greatly in excess of its Km in liver; this was not the case in heart and skeletal muscle, where 200,M would be -expected to support faster reaction rates with increasing pH (by virtue of their much higher Km for this substrate).
Experiments using octanoyl-CoA as the varied substrate were done with skeletal-muscle mitochondria, but interpretation of the data was complicated by the fact that Lineweaver-Burk plots deviated from linearity such that accurate kinetic constants could not be assigned. Nevertheless, it was intuitively obvious that the Km for the medium-chain substrate, though lower than that for palmitoyl-CoA, was unaffected by changes in pH, consonant with the findings obtained with the latter substrate. Vmax. with octanoyl-CoA was also lower than with palmitoyl-CoA and, as expected, increased with pH.
Effects ofpH on the kinetics ofmalonyl-CoA bindingThis series of experiments was performed with mitochondria from skeletal muscle and was designed to answer the following questions. First, could the fall in malonyl-CoA sensitivity of CPT I with increasing pH be explained by a diminution in malonyl-CoA binding to the mitochondrial membrane? Second, since fatty acyl-CoA species are competitive with respect to malonyl-CoA binding , how does pH affect this interaction? We have previously shown ) that rat skeletal-muscle mitochondria possess a single class of high-affinity binding site for malonyl-CoA. The effect of pH on this system is shown in Table 2 ).
Although Kd values for malonyl-CoA binding were generally less at the lower temperature, they were again increased disproportionately by palmitoylCoA as the pH was raised. The implication of these findings was that as pH increased palmitoyl-CoA became a more potent competitor for malonyl-CoA binding, suggesting that the affinity of the binding site for the two ligands was not being altered in the same fashion. What was not clear was whether the affinity of the malonyl-CoA site for palmitoyl-CoA was resistant to changes in pH, as was the Km of palmitoyl-CoA in the CPT I reaction (Table 1) . Theoretically, the affinity of the malonyl-CoA site for palmitoyl-CoA could be tested in two ways: either by examining directly the kinetics of labelled palmitoyl-CoA binding to mitochondria in the presence and absence of excess unlabelled malonyl-CoA, or by measuring the ability of unlabelled palmitoyl-CoA to compete with [I4C]malonyl-CoA for its receptor.
We chose the latter procedure because of the large amount of non-specific binding of the long-chain acyl-CoA predictable in the former method. The results are shown in Fig. 2 The results from the experiment of shown in line A of , the affinity of the malonyl-CoA binding site was greater for octanoyl-CoA than for palmitoyl-CoA ( (Stephens et al., 1983) . For reasons too extensive to elaborate upon here, we are reluctant at this stage to attach such teleological significance to the phenomenon. Rather, our major purpose in pursuing the observation was to gain further insight into the properties of this complex enzyme and the biochemical mechanism through which its activity is controlled by malonylCoA and related molecules. We believe the present studies have been informative on both counts.
The influence of pH on the malonyl-CoA sensitivity of mitochondrial CPT I is now seen to Vol. 219 CoA inhibition of CPT I at pH 7.4 found in the present studies are somewhat higher than those reported by us previously Mills et al., 1983) . The discrepancy stems from the fact that in the studies cited the final pH of the reaction mixture was inadvertently closer to 7.1 than 7.4.]
Another striking effect of pH was its ability to alter the Km of CPT I for carnitine. Of interest is the fact that in the three tissues we examined (selected on the basis of their low, intermediate and high sensitivity to malonyl-CoA) an increase in pH over the relatively narrow range 6.8-7.6 produced a similar loss in inhibitory potency of malonyl-CoA (about 80%) coupled with an identical decrease in the Km for carnitine (about 50%).
Thus, the same inverse relationship between I50
for malonyl-CoA and Km for carnitine seen previously across tissue and species lines at a fixed pH (McGarry et al., 1983) also appears to hold for any given tissue when the pH is changed (see below).
Two early observations with mitochondrial membranes from rat liver (McGarry et al., 1978a) had led us to suggest that, although the suppression of CPT I activity by malonyl-CoA could be overcome by increasing the concentration of palmitoyl-CoA, the interaction of substrate and inhibitor was not competitive in the classical sense. In the first place, the curve relating enzyme activity to substrate concentration confQrmed to a rectangular hyperbola in the absence of malonylCoA, but became sigmoid in the presence of the inhibitor. In addition, the detergent-solubilized enzyme lost all sensitivity to malonyl-CoA. These findings, which have since been confirmed in our and other laboratories (Bremer, 1981.; Saggerson, 1982; McGarry et al., 1983) , pointed to a more complex interaction between CPT I and malonylCoA than would be expected on the basis of simple competitive inhibition. The present studies provide additional support for such an interpretation. Key observations were as follows.
First, despite the fact that the inhibitory potency of malonyl-CoA was some 50 and 100 times greater, respectively, in heart and skeletal muscle than in liver, the Km for palmitoyl-CoA was similar in all three tissues.
Second, in any given tissue the Km for palmitoylCoA in the CPT I reaction was totally resistant to changes in pH. The same was true in skeletal muscle with octanoyl-CoA as substrate (liver and heart were not tested in this case). In striking contrast, the Kd for malonyl-CoA binding to skeletal-muscle mitochondria was profoundly pHsensitive. Thus the pH-induced shift in malonylCoA sensitivity of CPT I to inhibition by malonylCoA was the direct result of changes in the affinity for its binding at the malonyl-CoA site. This is in accord with our earlier conclusion that the degree of occupancy of this site by malonyl-CoA (or structurally related compounds) governs the activity of the muscle enzyme. It is likely that the same explanation will hold for other tissues. Third, the Kd values of the malonyl-CoA binding site for palmitoyl-CoA and octanoyl-CoA also changed markedly with pH. Interestingly, the affinity of this site for fatty acyl-CoA species and malonyl-CoA (or its analogues) responded in opposite fashion, the former increasing and the latter decreasing as the pH was raised. The net result was that, for a given increment in pH, the associated loss in malonyl-CoA sensitivity of the CPT I reaction was greater than would have been predicted simply on the basis of the altered Kd for malonyl-CoA binding seen in the absence of acylCoA.
What might these findings mean as regards the respective sites of interaction of substrates and inhibitors with CPT I as it exists on the mitochondrial inner membrane? Although the data do not allow a definitive answer, they could provide some clues. The fact that the affinity of the malonyl-CoA binding site for palmitoyl-CoA increased with pH, whereas the Km for palmitoylCoA in the CPT I reaction was pH-insensitive, raises the possibility that the locus of malonyl-CoA binding is distinct from the active site of CPT I. We recognize that such a construct hinges on the assumption that an unchanging Km for palmitoylCoA (in terms of enzyme activity with increasing pH) reflects an unchanging affinity (Ks) for this substrate at the active site. This is not necessarily true, and cannot be ascertained without more detailed knowledge of the reaction mechanism. Certainly, the fact that solubilized CPT is insensitive to malonyl-CoA is consistent with (although it does not prove) the existence of separate active and regulatory sites.
If the above formulation is correct, the further implication would be that palmitoyl-CoA or other acyl-CoA substrates bind both to the active site (pH-insensitive) and to the regulatory component (pH-sensitive) and that the latter is the locus at which fatty acyl-CoA species exert their competitive influence against malonyl-CoA. If this is true, it follows that the binding of malonyl-CoA (or related compounds such as methylmalonyl-CoA, succinyl-CoA and glutaryl-CoA) to the regulatory site must somehow dampen the catalytic efficiency of the active site. How this is accomplished is not known. Regardless of mechanism, if it is assumed that malonyl-CoA and acyl-CoA substrates bind to the same locus within the regulatory domain, a paradox is apparent. If mere occupancy of the regulatory site decreases enzyme activity, what prevents an acyl-CoA substrate from acting also as an inhibitor? One possibility would be that inhibitory ligands must be structurally quite similar to malonyl-CoA and possess a free carboxy group ). An alternative solution to the conundrum would be to suppose that the regulatory component contains two distinct sites, one for fatty acyl-CoA species and the other for malonyl-CoA and its analogues. According to this formulation, the binding of ligands to their respective sites would have to operate in a manner that would be indistinguishable from their binding to a common site on the basis of competitive displacement kinetics. Although direct evidence for such a model is still lacking, the fact that pH had opposite effects on the affinity of the regulatory component for fatty acyl-CoA species and malonyl-CoA would be consistent with it.
Finally, as alluded to above, another intriguing feature of this system is the reciprocal relationship noted in all of our studies between the affinity of the carnitine-binding site and that of the malonylCoA site for their respective ligands. The interesting possibility is raised that these two sites are closely associated, although, as shown previously , occupancy of one does not appear to influence the binding characteristics of the other. The fact that increasing pH enhanced the affinity of the enzyme for carnitine (which contains a positively charged nitrogen atom) while decreasing the binding of malonyl-CoA (negatively charged) could implicate the presence in the vicinity of both loci of a histidine residue which, as noted by Stephens et al. (1983) , might be expected to titrate over the pH range tested such that its net positive charge would fall with rising pH.
In conclusion, it is evident that the malonylCoA/CPT I interaction is not a simple one. Clearly established is the fact that the extent of malonylCoA binding to mitochondria is a key determinant of enzyme activity. The data suggest that the active site of the enzyme and the regulatory locus are distinct entities. However, direct proof for this concept will require experiments with solubilized CPT I and mitochondrial membranes.before and after the enzyme has been released. This work was supported by grants from the U.S. Public Health Service (AM 18573 and AM 07307). S. E. M. is a Recipient of National Research Service Award (AM 07139) from the National Institutes of Health. The expert technical assistance of Karen Herrmann-Thatcher and Murphy Daniels is gratefully acknowledged. We are also indebted to Dr. Louis Hersh for helpful discussions.
